Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications

被引:38
|
作者
Cui, Minghua
Gosu, Vijayakumar
Basith, Shaherin
Hong, Sunhye
Choi, Sun [1 ]
机构
[1] Ewha Womans Univ, Natl Leading Res Lab Mol Modeling & Drug Design N, Coll Pharm, Seoul, South Korea
关键词
ROOT GANGLION NEURONS; TRPV1; ION-CHANNEL; ANTAGONIST-INDUCED HYPERTHERMIA; CAPSAICIN-ACTIVATED CURRENTS; C-REGION ANALOGS; 3-PHASE; TRIALS; PAIN RELIEF; BODY-TEMPERATURE; VR1; RECEPTORS; IN-VIVO;
D O I
10.1016/bs.apcsb.2015.11.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transient receptor potential (TRP) channels belong to a superfamily of sensory-related ion channels responding to a wide variety of thermal, mechanical, or chemical stimuli. In an attempt to comprehend the piquancy and pain mechanism of the archetypal vanilloids, transient receptor potential vanilloid (TRPV) 1 was discovered. TRPV1, a well-established member of the TRP family, is implicated in a range of functions including inflammation, painful stimuli sensation, and mechanotransduction. TRPV1 channels are nonselective cation receptors that are gated by a broad array of noxious ligands. Such polymodal-sensor aspect makes the TRPV1 channel extremely versatile and important for its role in sensing burning pain. Besides ligands, TRPV1 signaling can also be modulated by lipids, secondary messengers, protein kinases, cytoskeleton, and several other proteins. Due to its central role in hyperalgesia transduction and inflammatory processes, it is considered as the primary pharmacological pain target. Moreover, understanding the structural and functional intricacies of the channel is indispensable for the therapeutic intervention of TRPV1 in pain and other pathological disorders. In this chapter, we seek to give a mechanistic outlook on the TRPV1 channel. Specifically, we will explore the TRPV1 structure, activation, modulation, ligands, and its therapeutic targeting. However, the major objective of this review is to highlight the fact that TRPV1 channel can be treated as an effective therapeutic target for treating several pain-and nonpain-related physiological and pathological states.
引用
收藏
页码:81 / 125
页数:45
相关论文
共 50 条
  • [21] Structure-Driven Pharmacology of Transient Receptor Potential Channel Vanilloid 1
    Diaz-Franulic, Ignacio
    Caceres-Molina, Javier
    Sepulveda, Romina V.
    Gonzalez-Nilo, Fernando
    Latorre, Ramon
    MOLECULAR PHARMACOLOGY, 2016, 90 (03) : 300 - 308
  • [22] Modulation of Transient Receptor Vanilloid 1 Activity by Transient Receptor Potential Ankyrin 1
    Spahn, Viola
    Stein, Christoph
    Zoellner, Christian
    MOLECULAR PHARMACOLOGY, 2014, 85 (02) : 335 - 344
  • [23] Activation of transient receptor potential vanilloid receptor type 1 inhibits human monocyte migration
    Liu, D. Y.
    Ma, L. Q.
    Luo, Z. D.
    Cao, T. B.
    Wang, L. J.
    Tepel, Martin
    Zhu, Z. M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E64 - E64
  • [24] Changes in transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 in patients with lower urinary tract dysfunction
    Cho, Kang Jun
    Koh, Jun Sung
    Choi, Jin Bong
    Park, Sang Hi
    Lee, Weon Sun
    Kim, Joon Chul
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (03) : 309 - 315
  • [25] Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist
    Fosgerau, Keld
    Weber, Uno J.
    Gotfredsen, Jacob W.
    Jayatissa, Magdalena
    Buus, Carsten
    Kristensen, Niels B.
    Vestergaard, Mogens
    Teschendorf, Peter
    Schneider, Andreas
    Hansen, Philip
    Raunso, Jakob
    Kober, Lars
    Torp-Pedersen, Christian
    Videbaek, Charlotte
    BMC CARDIOVASCULAR DISORDERS, 2010, 10
  • [26] Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist
    Keld Fosgerau
    Uno J Weber
    Jacob W Gotfredsen
    Magdalena Jayatissa
    Carsten Buus
    Niels B Kristensen
    Mogens Vestergaard
    Peter Teschendorf
    Andreas Schneider
    Philip Hansen
    Jakob Raunsø
    Lars Køber
    Christian Torp-Pedersen
    Charlotte Videbaek
    BMC Cardiovascular Disorders, 10
  • [27] Transient Receptor Potential Vanilloid 1-a Polymodal Nociceptive Receptor - Plays a Crucial Role in Formaldehyde-Induced Skin Inflammation in Mice
    Usuda, Haruki
    Endo, Takumi
    Shimouchi, Ayumi
    Saito, Asaka
    Tominaga, Makoto
    Yamashita, Hirotaka
    Nagai, Hiroichi
    Inagaki, Naoki
    Tanaka, Hiroyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 (02) : 266 - 274
  • [28] Transient Receptor Potential Vanilloid Type 1 Channel May Modulate Opioid Reward
    Thi-Lien Nguyen
    Seung-Hwan Kwon
    Sa-Ik Hong
    Shi-Xun Ma
    Yang-Hee Jung
    Ji-Young Hwang
    Hyoung-Chun Kim
    Seok-Yong Lee
    Choon-Gon Jang
    Neuropsychopharmacology, 2014, 39 : 2414 - 2422
  • [29] IS TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 (TRPV1) A NEW TARGET FOR CARDIOPROTECTION?
    AL-Mawla, R.
    Paita, L.
    Bidault-Ducreux, S.
    Chouabe, C.
    Durand, A.
    Augeul, L.
    Dupre-Aucouturier, S.
    Bonvallet, R.
    Ovize, M.
    Van Coppenolle, F.
    JOURNAL OF HYPERTENSION, 2016, 34 : E212 - E213
  • [30] Functional transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 channels along different segments of the renal vasculature
    Chen, L.
    Kassmann, M.
    Sendeski, M.
    Tsvetkov, D.
    Marko, L.
    Michalick, L.
    Riehle, M.
    Liedtke, W. B.
    Kuebler, W. M.
    Harteneck, C.
    Tepel, M.
    Patzak, A.
    Gollasch, M.
    ACTA PHYSIOLOGICA, 2015, 213 (02) : 481 - 491